8-K filing — Definitive Healthcare Corp. (DH)
Filed: 2026-09-09 AccNo: 0001193125-26-385950 Size: 160 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est
Definitive Healthcare (NASDAQ:DH) is looking for Q3 Adj EPS of $0.04-$0.05 vs $0.04 analyst estimate. sees sales of $54.000 million-$55.000 million vs $55.542 million analyst estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Definitive Healthcare shares are trading higher after the company confirmed the receipt of going-private proposal from Advent International. The company also announced the appointment of Clay Ritchey as its CEO.
Definitive Healthcare Special Committee Says It Received Non-Binding Indication Of Interest From Advent International To Take The Company Private And Acquire All Outstanding Class A Shares For $1.02/Share In Cash
Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop
Definitive Healthcare Corp. ("Definitive Healthcare") (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the